본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

편평세포암 동물 모델에서 고려인삼잎-다당체(MB40)의 항암치료효과

이용수 56

영문명
The Anti-tumor Effect of Polysaccharide from the Leaves of Panax Ginseng C.A. Meyer(MB40) in a Murine Squamous Cell Carcinoma Model
발행기관
대한두경부종양학회
저자명
주은정(Eun Jung Joo) 최 준(Jun Choi) 정은재(Eun Jae Chung) 홍석진(Seok Jin Hong) 조재구(Jae Gu Cho) 백승국(Seung Kuk Baek) 우정수(Jeong Soo Woo) 정광윤(Kwang Yoon Jung) 권순영(Soon Young Kwon)
간행물 정보
『대한두경부종양학회지』제25권 제1호, 3~7쪽, 전체 5쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
2009.05.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Background and Objectives:Panax ginseng C.A. Meyer is a medical plant that has been widely utilized as a tonic and nutritional agent since ancient times in Korea. Ginseng has anti-metastatic property of cancer and immunomodulating activity. The novel acidic polysaccharide compound(MB40) was isolated from the leaves of Panax ginseng C.A. Meyer. To determine immunomodulating activities of MB40, we evaluate anti-cancer and anti-metastatic effects of MB40 in tumor bearing immune competent mice. Material and Methods:C3H mice were divided into three equal groups(Cisplatin treatment group, MB40treat- ment group, Cisplatin and MB40 treatment group) and were transplanted SCC(Squamous Cell Carcinoma) cells(2×106) to the lateral side of abdomen. From day 4 after transplantation, MB40 was administrated at dose of 10mg/kg, respectively, every other day by intratumoral injection. Cisplatin was systemically administrated at doses of 1mg/kg, respectively, every week by intraperitoneal injection. Results:5 days after administration, tumors can be palpated in every mice group. After 13 days of administra-tion, the mice group to which MB40 were administrated exhibited reduction in tumor size respectively, com-pared to cisplatin group. Overall status of mice such as body weight and activity were superior in MB40 group than cisplatin group. Conclusion:The result of this study indicates MB40 may have significant therapeutic effect and decreases com-plications induced by systemic chemotheraphy. MB40 may be developed as a novel and potent immunotropics to improve the cell immune system and anti-cancer drug for the treatment of cancer patients in head and neck squamous cell carcinoma.

목차

서 론
대상 및 방법
결 과
고 찰
결 론

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

주은정(Eun Jung Joo),최 준(Jun Choi),정은재(Eun Jae Chung),홍석진(Seok Jin Hong),조재구(Jae Gu Cho),백승국(Seung Kuk Baek),우정수(Jeong Soo Woo),정광윤(Kwang Yoon Jung),권순영(Soon Young Kwon). (2009).편평세포암 동물 모델에서 고려인삼잎-다당체(MB40)의 항암치료효과. 대한두경부종양학회지, 25 (1), 3-7

MLA

주은정(Eun Jung Joo),최 준(Jun Choi),정은재(Eun Jae Chung),홍석진(Seok Jin Hong),조재구(Jae Gu Cho),백승국(Seung Kuk Baek),우정수(Jeong Soo Woo),정광윤(Kwang Yoon Jung),권순영(Soon Young Kwon). "편평세포암 동물 모델에서 고려인삼잎-다당체(MB40)의 항암치료효과." 대한두경부종양학회지, 25.1(2009): 3-7

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제